Prevalence of Obstructive Sleep Apnea Among Atrial Fibrillation Patients: A Cross-Sectional Study from Jordan

Overview

Journal J Multidiscip Healthc

Publisher Dove Medical Press

Specialty Health Services

Date 2024 Feb 20

PMID 38375526

Authors

Rasheed K Ibdah

Khaled J Zaitoun

Rana B Altawalbeh

Saad H Tayyem

Ulla A Nazzal

Sukaina I Rawashdeh

Yousef S Khader

Abdel-Hameed W Al-Mistarehi

Basheer Y Khassawneh

Affiliations

Soon will be listed here.

Abstract

Background: Obstructive Sleep Apnea (OSA) is a common respiratory disorder that causes intermittent upper airway collapse during sleep and can lead to various acute cardiovascular complications. Atrial Fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with an increased risk of cardiovascular hospitalization and all-cause mortality. Our study aimed to investigate the prevalence of individuals with AF and those considered at high risk for OSA.

Methods: A cross-sectional study was conducted with a population comprising patients who had visited KAUH cardiology clinics between 2017-2019; subjects were categorized into AF patients and general cardiology patients. Patients were surveyed for OSA using the Berlin Questionnaire to assess the degree of OSA symptoms and to classify patients into high- or low-risk groups based on their responses.

Results: Of the 656 patients, 545 met our inclusion criteria, of whom 192 were diagnosed with AF. Comparable demographic characteristics were observed between the AF and non-AF groups, barring higher rates of obesity (=0.001) and smoking (=0.042) in the AF group. The prevalence of high-risk OSA was significantly higher in AF patients (68.2%) compared to non-AF patients (29.4%), with an adjusted odds ratio of 2.473 times (95% CI: 1.434 -4.266, =0.001) greater for AF. The age, gender, and BMI categories did not differ significantly between the two groups. Binary logistic regression revealed significant associations between OSA and risk factors such as asthma (OR=4.408, 95% CI: 2.634-7.376, p=0.001).

Conclusion: These results serve to display a statistically significant increase in high-risk OSA in existing AF patients, irrespective of the presence of conventional OSA risk factors; this could imply a more immediate and direct relationship between both diseases and calls to include routine screening for OSA in patients diagnosed, newly or otherwise, with AF.

References

Ryan S . Mechanisms of cardiovascular disease in obstructive sleep apnoea. J Thorac Dis. 2019; 10(Suppl 34):S4201-S4211. PMC: 6321896. DOI: 10.21037/jtd.2018.08.56. View

Vyas V, Lambiase P . Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities. Arrhythm Electrophysiol Rev. 2019; 8(1):28-36. PMC: 6434511. DOI: 10.15420/aer.2018.76.2. View

Lavie C, Pandey A, Lau D, Alpert M, Sanders P . Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. J Am Coll Cardiol. 2017; 70(16):2022-2035. DOI: 10.1016/j.jacc.2017.09.002. View

Toraldo D, Passali D, Sanna A, De Nuccio F, Conte L, De Benedetto M . Cost-effectiveness strategies in OSAS management: a short review. Acta Otorhinolaryngol Ital. 2017; 37(6):447-453. PMC: 5782420. DOI: 10.14639/0392-100X-1520. View

Jean-Louis G, Zizi F, Brown D, Ogedegbe G, Borer J, McFarlane S . Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms. Minerva Pneumol. 2011; 48(4):277-293. PMC: 3106988. View

Garbarino S, Lanteri P, Durando P, Magnavita N, Sannita W . Co-Morbidity, Mortality, Quality of Life and the Healthcare/Welfare/Social Costs of Disordered Sleep: A Rapid Review. Int J Environ Res Public Health. 2016; 13(8). PMC: 4997517. DOI: 10.3390/ijerph13080831. View

Xu Z, Wu Y, Tai J, Feng G, Ge W, Zheng L . Risk factors of obstructive sleep apnea syndrome in children. J Otolaryngol Head Neck Surg. 2020; 49(1):11. PMC: 7057627. DOI: 10.1186/s40463-020-0404-1. View

Linz D, McEvoy R, Cowie M, Somers V, Nattel S, Levy P . Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review. JAMA Cardiol. 2018; 3(6):532-540. DOI: 10.1001/jamacardio.2018.0095. View

Kawakami H, Saito M, Kodera S, Fujii A, Nagai T, Uetani T . Cost-Effectiveness of Obstructive Sleep Apnea Screening and Treatment Before Catheter Ablation for Symptomatic Atrial Fibrillation. Circ Rep. 2021; 2(9):507-516. PMC: 7819651. DOI: 10.1253/circrep.CR-20-0074. View

10.

Petryszyn P, Niewinski P, Staniak A, Piotrowski P, Well A, Well M . Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis. PLoS One. 2019; 14(3):e0213198. PMC: 6426211. DOI: 10.1371/journal.pone.0213198. View

11.

Saeed S, Romarheim A, Solheim E, Bjorvatn B, Lehmann S . Cardiovascular remodeling in obstructive sleep apnea: focus on arterial stiffness, left ventricular geometry and atrial fibrillation. Expert Rev Cardiovasc Ther. 2022; 20(6):455-464. DOI: 10.1080/14779072.2022.2081547. View

12.

Santilli M, Manciocchi E, DAddazio G, Di Maria E, DAttilio M, Femminella B . Prevalence of Obstructive Sleep Apnea Syndrome: A Single-Center Retrospective Study. Int J Environ Res Public Health. 2021; 18(19). PMC: 8508429. DOI: 10.3390/ijerph181910277. View

13.

Latina J, Estes 3rd N, Garlitski A . The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay. Pulm Med. 2013; 2013:621736. PMC: 3600315. DOI: 10.1155/2013/621736. View

14.

Marulanda-Londono E, Chaturvedi S . The Interplay between Obstructive Sleep Apnea and Atrial Fibrillation. Front Neurol. 2018; 8:668. PMC: 5732262. DOI: 10.3389/fneur.2017.00668. View

15.

Krishnan V, Dixon-Williams S, Thornton J . Where there is smoke…there is sleep apnea: exploring the relationship between smoking and sleep apnea. Chest. 2014; 146(6):1673-1680. PMC: 4251622. DOI: 10.1378/chest.14-0772. View

16.

Andrade J, Khairy P, Dobrev D, Nattel S . The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014; 114(9):1453-68. DOI: 10.1161/CIRCRESAHA.114.303211. View

17.

Gami A, Pressman G, Caples S, Kanagala R, Gard J, Davison D . Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004; 110(4):364-7. DOI: 10.1161/01.CIR.0000136587.68725.8E. View

18.

Jean-Louis G, Zizi F, Clark L, Brown C, McFarlane S . Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med. 2008; 4(3):261-72. PMC: 2546461. View

19.

Dopp J, Reichmuth K, Morgan B . Obstructive sleep apnea and hypertension: mechanisms, evaluation, and management. Curr Hypertens Rep. 2008; 9(6):529-34. DOI: 10.1007/s11906-007-0095-2. View

20.

Meszaros M, Bikov A . Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia. Biomedicines. 2022; 10(11). PMC: 9687681. DOI: 10.3390/biomedicines10112754. View